Fylde and Wyre CCG Medicines Optimisation

Click each header to expand its content

Fylde and Wyre medicines RAG list

Application forms

Medicines commissioning policies

Actipatch for pain management 0.6 MB321
Albiglutide for type-2 diabetes mellitus 0.3 MB220
Alprostadil Cream For ED 0.3 MB237
Azelastine Fluticasone (Dymista) Nasal Spray 0.1 MB355
Bazedoxifene for oestrogen deficiency symptoms 0.3 MB211
Botulinum Toxin A for Spasticity and Contracture of the joint 0.3 MB234
Brimonidine For Erythema Of Rosacea 0.1 MB195
Brivaracetam for epilepsy 0.3 MB206
Budesonide multimatrix MMX 9mg prolonged release tablets 0.2 MB311
Certolizumab For Psoriatic Arthritis 0.1 MB170
Co-Proxamol For pain management 0.3 MB378
Co-trimoxazole for the prophylaxis of pneumocystis jirovecii (pneumocystis carinii) infections 0.3 MB222
Co-trimoxazole Prophylaxis of Primary and Secondary Spontaneous Bacterial Peritonitis (SBP) 0.1 MB274
Colesevelam (Cholestagel® ) For combination or monotherapy for familial hypercholesterolaemia 0.3 MB191
Colistimethate sodium/Colistin sulfomethate sodium (Colomycin® ) For non-Cystic Fibrosis in Patients with Bronchiectasis Colonised with Pseudomonas Aeruginosa 0.2 MB191
Conditions for which over the counter items should not routinely be prescribed in primary care 0.9 MB411
Daily selective serotonin re-uptake inhibitors (SSRIs) for the treatment of premature ejaculation (PE) 0.2 MB159
Dapoxetine for the treatment of premature ejaculation (PE) 0.2 MB161
Denosumab for GIO 0.2 MB146
Dulaglutide for the treatment of Type II Diabetes Mellitus in adults 0.3 MB238
Eflornithine-cream-for-facial-hirsutism 0.2 MB204
Eltrombopag For Thrombocytopenia In Hepatitis C 0.1 MB151
Eslicarbazepine For Focal Seizures 0.1 MB197
Evolocumab (Repatha SureClick® ) For prevention of cardiac events in patients with CHD and a history of ACS, in combination with a statin 0.1 MB177
Ferric Maltol 30mg Capsules in Adults for the Treatment of Iron Deficiency Anaemia in Patients with Inflammatory Bowel Disease 0.3 MB175
Fluorouracil-5-cream-for-basal-cell-carcinomas 0.1 MB212
Gluten-Free-Food-Products 0.3 MB227
Guanfacine-for-ADHD 0.3 MB166
Imiquimod-5-cream-for-basal-cell-carcinomas 0.2 MB164
Insulin Degludec And Liraglutide 0.2 MB182
Insulin-Aspart-for-Diabetes-Mellitus 0.3 MB204
Insulin-Degludec-for-DM 0.3 MB183
Insulin-Detemir-for-DM 0.2 MB143
Insuline-Glargine-for-T1DM 0.3 MB159
Insuline-Glargine-for-T2DM 0.3 MB163
Invicorp-injection-for-erectile-dysfunction 0.3 MB288
Ivermectin-cream-for-rosacea 0.3 MB175
JIA Policy For Adults (Version 1.0) 0.2 MB160
Lamotrigine-for-trigeminal-neuralgia 0.3 MB177
Lamotrigine-for-trigeminal-neuralgia 2 0.3 MB188
Levonorgestrel 13.5mg IUD 0.3 MB150
Lidocaine Plasters For PHN 0.2 MB171
Lidocaine-plasters-for-unlicensed-indications 0.3 MB257
Liothyronine-for-refractory-hypothyroidism 0.2 MB221
Liraglutide-for-obesity 0.3 MB178
Lisdexamfetamine-for-ADHD-in-adults 0.3 MB278
Lisdexamfetamine-for-ADHD-update 0.3 MB198
Lurasidone-for-Schizophrenia 0.3 MB203
Magnaspartate For Hypomagnesaemia 0.3 MB844
Metformin-for-reductionof-risk-or-delay-type-2-daibetes 0.2 MB157
Metformin-for-reductionof-risk-or-delay-type-2-daibetes 2 0.2 MB139
Midazolam-Epistatus-for-seizures 0.2 MB287
Opicapone-for-Parkinsons-disease-v2 0.5 MB197
Ospemifene for VVA 0.2 MB358
Oxycodone-Naloxone-for-Restless-legs 0.3 MB166
Paravit-CF-for-dietary-management-of-patients-with-cystic-fibrosis 0.2 MB840
Patiromer-for-hyperkalaemia 0.3 MB177
Patiromer-for-hyperkalaemia 2 0.3 MB199
Phosphodiesterase Type-5 Inhibitors 0.2 MB165
Pitolisant-for-Narcolepsyv2 0.3 MB209
Policy On Brand Inhaler Prescribing 0.3 MB420
Probiotics And VSL 0.3 MB191
Relvar Ellipta for COPD and asthma in adults 63 KB157
Rituximab-for-AIHA 0.4 MB188
Rituximab-for-ITP 0.4 MB167
Rivaroxaban-10mg-for-DVT-and-PE-and-extended-use 0.1 MB179
Safinamide-for-Parkinsons-disease 0.3 MB202
Second Line Anti-TNF For PsA 0.2 MB177
Second-generation-LA-antipsychotics 0.3 MB203
Secukinumab-for-Palmoplantar-psoriasis 0.3 MB163
Secukinumab-for-Palmoplantar-psoriasis 2 0.3 MB150
Semaglutide for type 2 DM 0.2 MB171
Silk Garments For Eczema And Dermatitis 0.2 MB162
Simbrinza for chronic open angle glaucoma 0.1 MB157
Sodium Oxybate for Narcolepsy with Cataplexy 0.3 MB232
Spironolactone For Acne 0.1 MB234
Subcutaneous Depot Medroxyprogesterone Acetate 0.1 MB173
Tadalafil daily 0.3 MB317
Tapentadol for neuropathic pain in non-palliative care 0.4 MB181
Tapentadol for non-specific pain 0.2 MB186
Testosterone For Female Sexual Dysfunction 0.1 MB191
Tiotropium For Asthma 0.2 MB152
Tocilizumab SC For RA 0.1 MB131
Trelegy inhaler for COPD 0.3 MB309
Trimbow inhaler for COPD 0.4 MB223
Trimbow-inhaler-for-COPD 0.4 MB6
Ulipristal acetate for uterine fibroids 0.5 MB170
Umeclidinium For COPD 0.2 MB169
Vedolizumab For Crohn's Disease 0.2 MB130
Vesomni For Benign Prostatic Hyperplasia 0.1 MB150
Vitamins (inc Renavit) For Dialysis 0.3 MB348
Waterproof Cast Cover Policy 0.1 MB478
Xonvea for nausea and vomiting in pregnancy 0.1 MB165

Medicines guidelines, information sheets, and shared care

Further medicines guidelines are available on Lancashire Medicines Management Group’s website.

Algorithm-for-antihyperglycaemic-therapy-in-adults-with-type-II-v1.5[3] 0.5 MB158
Antimicrobial Formulary 2020 0.7 MB65
Antimicrobial Summary additional information 2020 23 KB24
Asthma treatment guideline for children 0.4 MB93
Azathioprine-Mercaptopurine-SCG-Version 0.2 MB353
BGTS and Meters Guideline Nov16 1.2 MB1433
Cannabis-based-medicinal-products-for-pain-POSITION-STATEMENT-version-1.1[1] 0.3 MB122
Ciclosporin-SCG-Version 0.2 MB210
Commissioining Policy For Nutritional Supp Post Bariatirc Surgery Apr13 83 KB234
Conditions-for-which-OTC-items-should-not-routinely-be-prescribed-in-pri .. 0.9 MB287
Dalteparin SCG 2018 0.2 MB259
Electronic-Repeat-Dispensing-guideline 1.7 MB1672
Emollient-Guideline-May-2017 0.2 MB2483
Flash Glucose Monitoring policy - L&SC 0.2 MB213
Flowchart-for-Vitamin-D-Deficiency-in-Primary-Care 0.3 MB596
Guidance to support the implementation of the valproate PREVENT programme 0.5 MB342
Guidance-for-7-day-prescriptions-FWCCG-Apr2018 0.5 MB379
Lancashire and South Cumbria Self-Care and Acces to OTC Medicines – Temp... 83 KB86
Leflunomide-SCG-Version 0.2 MB204
LSCMMG OTC Items that Should not be Routinely Prescribed in Primary Care... 0.2 MB129
MDS Briefing Doc Oct 13 43 KB174
Methotrexate-SCG-Version 0.2 MB422
Patient information - Emollients.steroid.barrier creams 0.2 MB164
Patient information - Emollients.steroid.barrier creams 0.2 MB473
Patient information - spacer devices 0.2 MB202
Patient information - spacer devices 0.2 MB210
Penicillamine-SCG-Version 0.2 MB187
Policy Unlicensed Herbal Vits Mins Supplements 2013 77 KB136
Position Statement OPIOID PRESCRIBING max dose Final Version 1.1 0.1 MB126
Prescribing-Nutritional-Supplements-Post-Bariatric-Surgery-Version-1.2[1] 0.3 MB119
Prescribing-Nutritional-Supplements-Post-Bariatric-Surgery-Version-1.2[1] 0.3 MB97
RMOC-Liothyronine-Guidance-v2.0-final-1 0.5 MB177
Sodium-Aurothiomalate-SCG-Version 0.2 MB27
Sulfasalazine 0.2 MB311
Testosterone-Shared-Care-Guideline-Version-1.2[1] 0.3 MB115
Wound Care Formulary 8.2 MB1096

Primary care rebate schemes

Primary care rebate schemes are contractual arrangements offered by pharmaceutical companies, or third party companies, which offer retrospective financial rebates to the CCG on GP prescribing expenditure for particular branded medicine(s). The availability of a scheme does not influence the inclusion of specific medicines in care pathways or formularies.

Current Primary Care Rebate Schemes in place:

  • Clenil Modulite (Beclometasone) – Started July 2019
  • Fencino (Fentanyl) – Started April 2016
  • Firmagon (Degarelix) – Started September 2016
  • Januvia (Sitagliptin) – Started September 2018
  • Lixiana (Edoxaban) – Started February 2018
  • Longtec (Oxycodone SR) – Started July 2019
  • Sereflo (Fluticasone / Salmeterol) – Started July 2019
  • Seretide (Fluticasone / Salmeterol) – Started April 2016
  • Xarelto (Rivaroxaban) – Started October 2019
  • Zoladex (Goserelin) – Started January 2019

Fact and advice sheets

Inhaler Techniques

Inhaler technique videos are available to view online.

Last updated on 18 December 2019 at 11:14 by Senior communications and engagement officer N